VIVUS (STU:VIU1) FCF Margin % : 0.58% (As of Mar. 2020)

View and export this data going back to . Start your Free Trial

What is VIVUS FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. VIVUS's Free Cash Flow for the three months ended in Mar. 2020 was €0.10 Mil. VIVUS's Revenue for the three months ended in Mar. 2020 was €17.77 Mil. Therefore, VIVUS's FCF Margin % for the quarter that ended in Mar. 2020 was 0.58%.

As of today, VIVUS's current FCF Yield % is 0.00%.

The historical rank and industry rank for VIVUS's FCF Margin % or its related term are showing as below:

STU:VIU1' s FCF Margin % Range Over the Past 10 Years
Min: -31.85 Med: 0 Max: 0
Current: -31.85

STU:VIU1's FCF Margin % is not ranked
in the Biotechnology industry.
Industry Median: -145.04 vs STU:VIU1: -31.85

VIVUS FCF Margin % Historical Data

The historical data trend for VIVUS's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

VIVUS FCF Margin % Chart

VIVUS Annual Data

Trend

Dec10

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

FCF Margin %

Get a 7-Day Free Trial

-48.88

30.54

-25.07

-243.83

-43.75

VIVUS Quarterly Data
	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20
FCF Margin %	Get a 7-Day Free Trial															-43.12	-57.20	-31.38	-42.87	0.58

Competitive Comparison of VIVUS's FCF Margin %

For the Biotechnology subindustry, VIVUS's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

VIVUS's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, VIVUS's FCF Margin % distribution charts can be found below:

* The bar in red indicates where VIVUS's FCF Margin % falls into.

VIVUS FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

VIVUS's FCF Margin for the fiscal year that ended in Dec. 2019 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2019 )	/	Revenue (A: Dec. 2019 )
	=	-27.465	/	62.784
	=	-43.75 %

VIVUS's FCF Margin for the quarter that ended in Mar. 2020 is calculated as

FCF Margin	=	Free Cash Flow (Q: Mar. 2020 )	/	Revenue (Q: Mar. 2020 )
	=	0.103	/	17.766
	=	0.58 %

VIVUS FCF Margin % Related Terms

Thank you for viewing the detailed overview of VIVUS's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

VIVUS (STU:VIU1) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » VIVUS Inc (STU:VIU1) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

900 East Hamilton Avenue, Suite 550, Campbell, CA, USA, 95008

Website

http://www.vivus.com

VIVUS Inc is a US-based biopharmaceutical company engaged in developing and commercializing, next-generation therapies to address unmet medical needs in human health. Its commercial products include Qsymia, an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adult patients with an initial body mass index; PANCREAZE which is a is a pancreatic enzyme preparation consisting of pancrelipase, an extract derived from porcine pancreatic glands, as well as other enzyme classes and STENDRA/SPEDRA, which is an oral phosphodiesterase type 5 inhibitor for the treatment of erectile dysfunction.

VIVUS (STU:VIU1) Headlines

No Headlines